Drug recall · May 1, 2019
Labetalol 20 mg/4 mL recall
Why: Lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Labetalol 20 mg/4 mL, 20 mg in 4 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Lots / codes
Lots: EA241908 Exp. 4/24/2019; EB011905 Exp. 5/2/2019; EB081909 Exp. 5/9/2019; EB151910 Exp. 5/16/2019; EB251909 Exp. 5/26/2019; EC061907 Exp. 6/4/2019; EC151906 Exp. 6/13/2019
- Quantity
- 6667 syringes
- Company
- CMC Enterprise Pharmacy, Charlotte, NC
- Distribution
- NC
- Initiated
- April 12, 2019 · Voluntary: Firm initiated
- Classified
- April 23, 2019
- Reported
- May 1, 2019
- Ended
- October 30, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Labetalol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.